Should we move to a genomic classification of neutrophilic myeloid neoplasms?

Blood Adv. 2023 Nov 14;7(21):6705-6706. doi: 10.1182/bloodadvances.2023011103.
No abstract available

Publication types

  • Comment

MeSH terms

  • Genomics
  • Humans
  • Myeloproliferative Disorders* / genetics
  • Neoplasms*